Go to main content

Department of Clinical Immunology

The Department of Clinical Immunology consists of the Region Hovedstaden Blood Bank, specializing in transfusion medicine, the cell and tissue bank, specializing in transplantation medicine, and Tissue Typing Laboratory 7631, where we perform tissue typing and immunological diagnostics.

About us

Department of Clinical Immunology is one of Northern Europe's largest, with a production of 150,000 blood cell, and tissue components, as well as approximately 1 million analyses for patient treatment. In addition, plasma is collected for the manufacture of medicine for Danish patients. Based at Rigshospitalet and with expertise in all clinical immunological areas, the department participates in new treatments, including stem cell therapies and treatment of transfusion-dependent diseases in fetuses and children.

Management

Morten Bagge Hansen

Head of Department, Consultant, dr. med

Email: morten.bagge.hansen@regionh.dk

Phone: +45 3545 2583

Tanja Tellier

Lead Laboratory Technologist

Email: Tanja.Tellier.01@regionh.dk

Phone +45 3545 3471.

Research

Morten Hanefeld Dziegiel

Professor, Consultant, Ph.d.

> Publications

Peter Garred

Professor, Consultant, dr. med.
Tissue Typing Laboratory

Pär Johansson

Professor, Consultant, dr. med., MPA
Blood Bank

> Publications
> Research Team

Sisse Rye Ostrowski

Professor, Consultant, ph.d., dr.med.
Head of Studies for Master in Personalized Medicin

> Publications
> Professor profile

Associate professor

Morten Bagge Hansen

Head of Department, dr.med.

Contact

Blood Bank

Rigshospitalet
2034
Blegdamsvej 9
Copenhagen OE 2100

Phone: +45 3545 2032
Email: 2034.rigshospitalet@regionh.dk

Tissue Typing Laboratory

7631

Tagensvej 20/Ole Maaløesvej 26
Copenhagen OE 2200

Phone: +45 3545 7631
Fax: 3539 8766
Email: 7631.rigshospitalet@regionh.dk

News from Rigshospitalet

Rigshospitalet recognized among the world’s best hospitals in 2026

The 2026 edition of World’s Best Hospitals, published annually by Newsweek, places two Nordic hospitals among the global top fifteen, with Rigshospitalet – Copenhagen University Hospital at 15th place and Karolinska University Hospital at 4th place worldwide. It is an acknowledgement of the strong tradition for high‑quality, publicly funded healthcare in the Nordic region.

Innovation District Copenhagen appoints new CEO

Innovation District Copenhagen (IDC) has appointed Annemarie Munk Riis as its new Chief Executive Officer, taking up the position on June 1st 2026. She arrives directly from a position as CEO at Green Building Council and holds a degree in economics from the University of Copenhagen and a PhD from Copenhagen Business School.

CollaborationSkåneRH

New Danish–Swedish hospital collaboration to boost research and patient treatment

Conducting large clinical studies and sharing research data between Sweden and Denmark is about to become easier. Rigshospitalet, Copenhagen University Hospital and Skåne University Hospital have signed a Memorandum of Understanding to facilitate cross-border collaboration and strengthen health innovation in the Öresund Region.

Sensory play installations will create a safer hospital experience for children across the country

New play installations at Mary Elizabeths Hospital, Aalborg University Hospital, and Sygehus Lillebælt will help children feel calmer and more confident before medical examinations. Nordea-fonden is funding the project with DKK 12.25 million.

13. January 2026

2025 Highlights from the Phase 1 Unit at Rigshospitalet

In 2025, the Phase 1 Unit at Rigshospitalet continued to strengthen its position as a leading Nordic site for early-phase clinical research, supporting partners and sponsors in the efficient and safe development of innovative therapies.

17. December 2025

Building Europe’s Future Through Collaboration

Explore the report Recommendations for the implementation of the EU Life Science Strategy

3. December 2025

The “Improvement Engine” for the Sickest Patients

After years of preparation, intensive care units across Denmark have begun enrolling patients in the INCEPT platform trial, which tests multiple treatments at once to improve care for the most critically ill.

24. November 2025

ProTarget results presented at ESMO, 2025

ProTarget participated in this year’s ESMO Congress with a poster presentation, sharing results from the first 301 patients enrolled in the trial.

10. November 2025

Comprehensive genomic profiling of CNS tumors reveals rare SETD2 alterations with-out increased mutational burden

SETD2 loss does not confer the same mutational signature in CNS tumors as observed in other tumor types – results presented at AACR-NCI-EORT Molecular Targets and Cancer Therapies congress 2025.

5. November 2025

International award for pioneer in rare diseases

This year’s international research award from Rigshospitalet goes to German professor Heymut Omran. His research has, among other things, paved the way for new treatments and improved diagnostics for patients with a rare respiratory disease.